Canadian Epilepsy Alliance Demands Answers from Drug Makers Over Shortages

February 11, 2016 – The Canadian Epilepsy Alliance/Alliance canadienne de l’épilepsie is calling on drug manufacturers to take real steps to ensure patient safety and reduce shortages of anti-seizure medications, beginning with public disclosure of what is causing the shortages.

It is with tremendous concern that members of Canada’s epilepsy community have watched the on-going problem of drug shortages develop over recent years.

“The seemingly endless situation of one or more anti-seizure medications being in shortage has significantly worsened over recent weeks,” said CEA President Deirdre Floyd. “Across the country the supply of an essential medication, divalproex sodium (Epival), has been hit by recent shortages. A major Canadian pharmaceutical company is out-of-stock on multiple epilepsy drugs. This needs to stop and that’s not going to happen until we know why it’s happening at all”.

click here to read the full statement (English)

cliquez ici  pour l’énoncé de l’Alliance Canadienne de l’Épilepsie (Français)

For additional background information on drug shortages click here